Literature DB >> 24301220

Evaluating space-time models for short-term cancer mortality risk predictions in small areas.

Jaione Etxeberria1, Tomás Goicoa, Maria D Ugarte, Ana F Militino.   

Abstract

Current cancer mortality data are available with a delay of roughly three years due to the administrative procedure necessary to create the registries. Therefore, health agencies rely on forecast cancer deaths. In this context, statistical procedures providing mortality/incidence risk predictions for different regions or health areas are very useful. These predictions are essential for defining priorities for cancer prevention and treatment. The main objective of this work is to evaluate the predictive performance of alternative spatio-temporal models for short-term cancer risk/counts prediction in small areas. All the models analyzed here are presented under a general-mixed model framework, providing a unified structure of presentation and facilitating the use of similar tools for computing the prediction mean squared error. Prostate cancer mortality data are used to illustrate the behavior of the different models in Spanish provinces.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CAR models; Prostate cancer; Pspline models; Risks/counts predictions; Space-time disease mapping

Mesh:

Year:  2013        PMID: 24301220     DOI: 10.1002/bimj.201200259

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  2 in total

1.  Bayesian penalized spline models for the analysis of spatio-temporal count data.

Authors:  Cici Bauer; Jon Wakefield; Håvard Rue; Steve Self; Zijian Feng; Yu Wang
Journal:  Stat Med       Date:  2015-11-03       Impact factor: 2.373

2.  The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting.

Authors:  James E Bennett; Guangquan Li; Kyle Foreman; Nicky Best; Vasilis Kontis; Clare Pearson; Peter Hambly; Majid Ezzati
Journal:  Lancet       Date:  2015-04-29       Impact factor: 79.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.